- Home
- IVVD vs MLSS Comparison
IVVD vs MLSS Comparison
Compare IVVD & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVVD
- MLSS
- Stock Information
- Founded
- IVVD 2020
- MLSS 1989
- Country
- IVVD United States
- MLSS United States
- Employees
- IVVD N/A
- MLSS N/A
- Industry
- IVVD Biotechnology: Pharmaceutical Preparations
- MLSS Industrial Specialties
- Sector
- IVVD Health Care
- MLSS Health Care
- Exchange
- IVVD Nasdaq
- MLSS Nasdaq
- Market Cap
- IVVD 69.0M
- MLSS 74.9M
- IPO Year
- IVVD 2021
- MLSS 1995
- Fundamental
- Price
- IVVD $0.75
- MLSS $0.87
- Analyst Decision
- IVVD Strong Buy
- MLSS Buy
- Analyst Count
- IVVD 3
- MLSS 1
- Target Price
- IVVD $5.85
- MLSS $1.25
- AVG Volume (30 Days)
- IVVD 1.8M
- MLSS 61.9K
- Earning Date
- IVVD 08-13-2025
- MLSS 08-13-2025
- Dividend Yield
- IVVD N/A
- MLSS N/A
- EPS Growth
- IVVD N/A
- MLSS N/A
- EPS
- IVVD N/A
- MLSS N/A
- Revenue
- IVVD $36,688,000.00
- MLSS $8,613,503.00
- Revenue This Year
- IVVD $446.60
- MLSS $29.14
- Revenue Next Year
- IVVD $112.63
- MLSS $20.19
- P/E Ratio
- IVVD N/A
- MLSS N/A
- Revenue Growth
- IVVD N/A
- MLSS N/A
- 52 Week Low
- IVVD $0.35
- MLSS $0.58
- 52 Week High
- IVVD $2.74
- MLSS $1.39
- Technical
- Relative Strength Index (RSI)
- IVVD 43.27
- MLSS 40.16
- Support Level
- IVVD $0.70
- MLSS $0.86
- Resistance Level
- IVVD $1.03
- MLSS $0.92
- Average True Range (ATR)
- IVVD 0.07
- MLSS 0.03
- MACD
- IVVD -0.03
- MLSS -0.00
- Stochastic Oscillator
- IVVD 12.75
- MLSS 16.67
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.